GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Price-to-Funds-From-Operations

Cangene (FRA:YGE) Price-to-Funds-From-Operations : (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Cangene Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Cangene (FRA:YGE) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.